ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,964
Screening encounters
2,114
Diagnostic referrals
406
Outstanding pathways
178

Screening pathway

  1. Screening2,114Encounters
  2. Positive finding712Documented findings
  3. Referral406Diagnostic referrals
  4. Follow-up434Diagnostic visits
  5. Outcome228Resolved pathways

Stage totals use different units. Pending pathways: 178. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0337 · EXP-0337Synthetic · Site B

Full participant history through 2025-12-17, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · HSIL · Adequate
  3. · Diagnostic referral · EXP-0337-T-R
  4. · Contact attempt · Unsuccessful
  5. · Barrier documented · Transport difficulty
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Unsuccessful
  9. · Navigation intervention · Coordination support
  10. · Diagnostic visit · Missed
  11. · Diagnostic booking · Rebooking
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-06-16
  16. · Follow-up disposition · Resolved · EXP-0337-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

1964 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0356 · Expanded synthetic participant 0356Site B — Peri-Urban Access Programme
EXP-0358 · Expanded synthetic participant 0358Site B — Peri-Urban Access Programme
EXP-0360 · Expanded synthetic participant 0360Site E — Resource-Constrained Navigation Programme
EXP-0361 · Expanded synthetic participant 0361Site B — Peri-Urban Access Programme
EXP-0364 · Expanded synthetic participant 0364Site B — Peri-Urban Access Programme
EXP-0365 · Expanded synthetic participant 0365Site A — Urban Referral Hub
EXP-0369 · Expanded synthetic participant 0369Site D — Community Engagement Programme
EXP-0370 · Expanded synthetic participant 0370Site C — Rural Outreach Programme
EXP-0372 · Expanded synthetic participant 0372Site E — Resource-Constrained Navigation Programme
EXP-0375 · Expanded synthetic participant 0375Site C — Rural Outreach Programme
EXP-0376 · Expanded synthetic participant 0376Site D — Community Engagement Programme
EXP-0377 · Expanded synthetic participant 0377Site D — Community Engagement Programme
EXP-0380 · Expanded synthetic participant 0380Site B — Peri-Urban Access Programme
EXP-0382 · Expanded synthetic participant 0382Site D — Community Engagement Programme
EXP-0386 · Expanded synthetic participant 0386Site B — Peri-Urban Access Programme
EXP-0387 · Expanded synthetic participant 0387Site D — Community Engagement Programme
EXP-0390 · Expanded synthetic participant 0390Site E — Resource-Constrained Navigation Programme
EXP-0391 · Expanded synthetic participant 0391Site C — Rural Outreach Programme
EXP-0392 · Expanded synthetic participant 0392Site C — Rural Outreach Programme
EXP-0396 · Expanded synthetic participant 0396Site A — Urban Referral Hub
EXP-0397 · Expanded synthetic participant 0397Site D — Community Engagement Programme
EXP-0399 · Expanded synthetic participant 0399Site B — Peri-Urban Access Programme
EXP-0401 · Expanded synthetic participant 0401Site E — Resource-Constrained Navigation Programme
EXP-0402 · Expanded synthetic participant 0402Site B — Peri-Urban Access Programme
EXP-0403 · Expanded synthetic participant 0403Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
901
HPV DNA
907
Cytology
306

Navigation activity

Barrier documented
331
Contact attempt
600
Navigation intervention
133
Diagnostic booking
494
Diagnostic visit
434

Documented barriers

Contact difficulty
97
Transport difficulty
113
Appointment coordination
121

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.